Skip NavigationSkip to Content

T-cell responses to KSHV infection: a systematic approach

  1. Author:
    Roshan, Romin
    Labo, Nazzarena
    Trivett, Matthew
    Miley, Wendell
    Marshall, Vickie
    Coren, Lori
    Cornejo Castro, Elena
    Perez, Hannah
    Holdridge, Benjamin
    Davis, Eliza
    Matus Nicodemos, Rodrigo
    Ayala, Victor I
    Sowder, Raymond
    Wyvill, Kathleen
    Aleman, Karen
    Fennessey, Christine
    Lifson, Jeffrey
    Polizzotto, Mark N
    Douek, Daniel
    Keele, Brandon
    Uldrick, Thomas
    Yarchoan, Robert
    Ohlen, Claes
    Ott, David
    Whitby, Denise
  2. Author Address

    AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Vaccine Research Center, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA., HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA.,
    1. Year: 2017
    2. Date: Dec 12
    3. Epub Date: 2017 11 25
  1. Journal: Oncotarget
    1. 8
    2. 65
    3. Pages: 109402-109416
  2. Type of Article: Article
  1. Abstract:

    Prior studies of T-cell responses to KSHV have included relatively few participants and focused on relatively few KSHV antigens. To provide a more comprehensive analysis, we investigated T-cell responses to the whole KSHV proteome using IFN-? ELISpot. Using ~7,500 overlapping 15mer peptides we generated one to three peptide pools for each of the 82 KSHV ORFs. IFN-? ELISpot analysis of PBMCs from 19 patients with a history of KSHV-associated disease and 24 healthy donors (11 KSHV seropositive) detected widely varied responses. Fifty six of the 82 ORFs were recognized by at least one individual but there was little overlap between participants. Responses to at least one ORF pool were observed in all 19 patients and in 7 seropositive donors. Four seropositive donors and 10 seronegative donors had no detectable responses while 3 seronegative donors had weak responses to one ORF. Patients recognised more ORFs than the donors (p=0.04) but the response intensity (spot forming units: SFU per million cells) was similar in the two groups. In four of the responding donors, individual peptides eliciting the predominant responses were identified: three donors responded to only one peptide per ORF, while one recognized five. Using intracellular cytokine staining in four participant samples, we detected peptide-induced IFN-?, MIP1-ß, and TNF-a as well as CD107a degranulation, consistent with multifunctional effector responses in CD8+ and CD4+ T cells. Sequence analysis of TCRs present in peptide specific T-cell clones generated from two participants showed both mono- and multi-clonotypic responses. Finally, we molecularly cloned the KSHV specific TCRs and incorporated the sequences into retroviral vectors to transfer the specificities to fresh donor cells for additional studies. This study suggests that KSHV infected individuals respond to diverse KSHV antigens, consistent with a lack of shared immunodominance and establishes useful tools to facilitate KSHV immunology studies.

    See More

External Sources

  1. DOI: 10.18632/oncotarget.22683
  2. PMID: 29312617
  3. PMCID: PMC5752530
  4. WOS: 000419565400089
  5. PII : 22683

Library Notes

  1. Fiscal Year: FY2017-2018
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel